Dirofilariasis is a helminthic infection caused by filarial parasite of the genus Dirofilaria. It is a common zoonotic disease mostly affecting canines and uncommon in humans. It is endemic to Mediterranean countries, with few reports from other parts of the world. The clinical forms in humans are pulmonary, subcutaneous, and ocular. Ocular involvement is rare. We report a case of lacrimal gland dirofilariasis, an unusual ocular presentation which masquerades as a lacrimal gland tumor. Ours would be the third reported case in the world and first in India. This case was managed with excision of the lacrimal gland mass. Postoperatively the patient recovered completely and there has been no recurrence in the 1-year follow-up.
<p>Parathyroid adenoma is associated with both primary and secondary hyperparathyroidism (SHPT). Identification of the adenoma requires a combination of clinical evidence, imaging information and cytological findings due to the challenging distinction between thyroid and parathyroid lesions. Sometimes ultrasound and even fine needle aspiration studies cannot distinguish this lesion from thyroid lesions. We present a case who was incidentally detected to have nodule in the (R) lobe of thyroid on CE-MRI. FNAC was suggestive of follicular neoplasm so managed as right hemithyroidectomy but the final diagnosis was made as parathyroid adenoma on the basis of histopathological examination and immunohistochemistry. Patient was evaluated retrospectively utilizing serum PTH levels, 24 hours urine calcium levels, inorganic phosphorus and USG KUB which turn out to be vitamin D deficiency induced SHPT and was managed with vit D3 supplements.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.